483sOnline Subscribe

Search By Date Issued

Search By Category

Drug
Device
Clinical

Search By Company/

Clinical Investigator

Search By Region

Search By FDA Investigator

Search By Keyword

Log in to start searching through our library of thousands of 483s, or Subscribe Now to 483sOnline.com to uncover exactly what FDA Inspectors are thinking about. It’s your own personal pre-investigation intelligence tool that identifies exactly what investigators are focusing on so you can be prepared – before they show up.

Cunningpac CC - Dec. 7, 2018

Issue Date

Dec 07, 2018

Region

HQ

Category

Drug
$117.00

Cunningpac CC

Contact Name

Graham Cunningpac

Contact Title

Director

Form483 Address 1

22 Bulman, Mkondeni

Form483 Address 2

Form483 City

Pietermaritzburg

Form483 State

Kwa Zulu Natal

Form483 Postal

3201

Form483 Country

South Africa

Inspection Range

Dec 06, 2018 - Dec 07, 2018

Pages

4

First Observation

Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory conformance to the final specifications and identity and strength of each active ingredient prior to release.
Investigator(s): Cheryl A. Clausen